Kiniksa pharmaceuticals ltd.

Major-Pharmaceuticals

KNSA


Clarendon House
Hamilton , HM 11

Executive/
Director

Price

  • Last Close
  • $ 18.58
    $ +0.06 0.32 %
    Jun 27, 2024
  • 52-Week High/Low
  • $21.74 - $14.37
  • YTD
  • 0%

  • Trading Volume
  • 6,761
  • Market Cap Full
  • $ 1.3B
  • Shares Outstanding
  • 69.8M
    Mar 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - -35.7% -5% 7.2% -15.6% -28.2% 12.5% -
Q2 - - -10.9% -25.3% 4% -24.7% -2.5% 30.9% -4.9% -
Q3 - - 50.7% -36.7% 8% -18.2% 32.5% 23.4% - -
Q4 - - 17.4% 27.6% 14.8% 3.3% 16.7% 3.8% - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 0.5% 19.9% -6.7% -5.1% - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-61%57%-32%27%17%6%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -6.45 -1.27 -0.48 -0.72 -0.36 -0.18
Q2 - - -0.97 -0.68 -0.65 -0.61 -0.29 0.21
Q3 - - -0.51 -0.49 -0.66 -0.44 3.18 -0.20
Q4 - - 4.44 -0.55 -0.82 -0.53 0.07 -
A 0 0 -3.5 -3 -2.6 -2.3 2.6 -0.17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - - 68.3 69.1 69.8
Jun - - 68.4 69.3 -
Sep - - 68.7 69.4 -
Dec 54 61.8 68.6 69.4 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.1 2.3 - - -
Fixed Asset Turnover 27.5 3.3 - - -
Total Asset Turnover 0.5 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -0.1 -157 -39.3 21.3 21.6
Equity multiplier - 0.1 - - -